<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03039283</url>
  </required_header>
  <id_info>
    <org_study_id>CEL5661</org_study_id>
    <nct_id>NCT03039283</nct_id>
  </id_info>
  <brief_title>Retrospective CI532 Hearing Performance</brief_title>
  <official_title>Retrospective Post-market Hearing Performance Outcome in a Cohort of CI532 Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cochlear</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cochlear</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this retrospective study is to collect and assess hearing performance data that
      have been measured by five clinics in Germany as part of their clinical routine in recipients
      implanted with a commercial CI532.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Speech understanding data in quiet and in noise and aided and unaided thresholds, medical
      history, anomalies in terms of electrode placement are collected through an eCRF. Recipient's
      device characteristics are collected through cdx files. Surgeon handling and usability of
      CI532 are collected through paper questionnaire.

      The retrospective study is aimed at collection of data for CI532 recipients who have routine
      hearing measures at pre-implant and post-implant intervals in their medical records.

      Patients are approached for study participation by the caring clinician on a consecutive and
      voluntary basis and on condition of signing the patient informed consent.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 14, 2017</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from pre-operative (daily listening condition) baseline speech understanding in quiet and in noise at 6 months post-operative (best aided conditions).</measure>
    <time_frame>pre-operatively and at 6 months post-operatively</time_frame>
    <description>Is tested using the centre's clinical routine speech tests</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The proportion of the recipient cohort in percent examined showing post-operative improvement per test and listening condition.</measure>
    <time_frame>pre-operatively</time_frame>
    <description>Is tested using the centre's clinical routine speech</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The proportion of the recipient cohort in percent examined showing post-operative improvement per test and listening condition.</measure>
    <time_frame>6 months post-operatively</time_frame>
    <description>Is tested using the centre's clinical routine speech</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Nucleus CI532 cochlear implant</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nucleus CI532 cochlear implant</intervention_name>
    <description>Retrospective study of the commercial CI532 cochlear implant</description>
    <arm_group_label>Nucleus CI532 cochlear implant</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients implanted with a commercial CI532 and for which clinical routine hearing measures
        data are available in their medical records.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ability to conduct adult hearing performance test material

          -  Good German language skills to assess clinical hearing performance

          -  CI532 recipients assessed via routine clinical measurements at pre implant, and post
             implant intervals with available data records in hospital files.

          -  Patients that have read, understood and signed the patient informed consent.

        Exclusion Criteria:

          -  Recipients that have participated in the CLTD5446 study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bart Volckaerts, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Cochlear</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicole Neben, Dr., Dipl.-Ing.</last_name>
    <phone>+49-511-542-77220</phone>
    <email>nneben@cochlear.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde</name>
      <address>
        <city>Freiburg im Breisgau</city>
        <state>Baden-Württemberg</state>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen, Hals-Nasen-Ohren-Klinik</name>
      <address>
        <city>Erlangen</city>
        <state>Bavaria</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum der J. W. Goethe-Universität Frankfurt</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hesse</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Deutsches HörZentrum Hannover der HNO-Klinik der MHH</name>
      <address>
        <city>Hannover</city>
        <state>Lower Saxony</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>: Klinik für Hals-, Nasen-, Ohrenheilkunde, Kopf- und Halschirurgie</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig-Holstein</state>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Holden LK, Finley CC, Firszt JB, Holden TA, Brenner C, Potts LG, Gotter BD, Vanderhoof SS, Mispagel K, Heydebrand G, Skinner MW. Factors affecting open-set word recognition in adults with cochlear implants. Ear Hear. 2013 May-Jun;34(3):342-60. doi: 10.1097/AUD.0b013e3182741aa7.</citation>
    <PMID>23348845</PMID>
  </reference>
  <reference>
    <citation>Dowell RC, Hollow R, Winton E. Outcomes for cochlear implant users with significant residual hearing: implications for selection criteria in children. Arch Otolaryngol Head Neck Surg. 2004 May;130(5):575-81.</citation>
    <PMID>15148179</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2017</study_first_submitted>
  <study_first_submitted_qc>January 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2017</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Moderate to profound sensorineural hearing loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

